HomeNewsmigraineTENS could be a new treatment for Migraine, finds study

TENS could be a new treatment for Migraine, finds study

  • June 5, 2018
  • Posted by: PharmaScroll
  • Category:
No Comments

Portrait of stressed young housewife in modern kitchen

Transcutaneous electrical nerve stimulation(TENS) has been applied as an abortive and prophylactic treatment for migraine in the recent times. The study, published in Springer Link Journal, conducted a meta-analysis to analyze the effectiveness and safety of TENS on migraineurs.

The researchers searched Medline (via PubMed), Embase, the Cochrane Library and the Cochrane Central Register of Controlled Trials to identify randomized controlled trials, which compared the effect of TENS with sham TENS on migraineurs. Data were extracted and methodological quality assessed independently by two reviewers. Change in the number of monthly headache days, responder rate, painkiller intake, adverse events and satisfaction were extracted as outcome.

Results of the study:

Four studies were included in the quantitative analysis with 161 migraine patients in real TENS group and 115 in sham TENS group. The researchers found significant reduction of monthly headache days (SMD: -0.48; 95% CI: -0.73 to − 0.23; P < 0.001) and painkiller intake (SMD: -0.78; 95% CI: -1.14 to − 0.42; P < 0.001). Responder rate (RR: 4.05; 95% CI: 2.06 to 7.97; P < 0.001) and satisfaction (RR: 1.85; 95% CI: 1.31 to 2,61; P < 0.001) were significantly increased compared with sham TENS.

The meta-analysis suggested that TENS may serve as an effective and well-tolerated alternative for migraineurs. The study further underlined that future well-designed RCTs are necessary to confirm and update the findings of the analysis.

 

About Pharmascroll:

Pharmascroll is a diligent business consulting and market research firm focused solely towards pharmaceutical markets. The company consults and researches in majorly chronic disease indications prevalent across the globe. The research conducted by Pharmascroll analysts is targeted to provide analytical and logical answers to the key business questions of the pharmaceutical and medical insights teams and to make better informed business decisions with the detailed relevant information available.

To read more news about Migraine, visit https://pharmascroll.com/news-category/migraine/

 

News Source: https://link.springer.com/article/10.1186%2Fs10194-018-0868-9

Image Source: https://www.telenews.pk/a-latest-drug-may-be-able-to-stop-migraines-before-they-even-begin/